The Enterprise Value as of December 2025 (TTM) for Stem Cell Authority, Ltd. (SCAL) is 8.73K

According to Stem Cell Authority, Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.73K. This represents a change of Infinity% compared to the average of 0 of the last 4 quarters.

Stem Cell Authority, Ltd. (SCAL) Historical Enterprise Value (quarterly & annually)

How has SCAL Enterprise Value performed in the past?

The mean historical Enterprise Value of Stem Cell Authority, Ltd. over the last ten years is 80.01K. The current 8.73K Enterprise Value has changed 990.74% with respect to the historical average. Over the past ten years (40 quarters), SCAL's Enterprise Value was at its highest in in the February 2023 quarter at 0. The Enterprise Value was at its lowest in in the February 2023 quarter at 0.

Stem Cell Authority, Ltd. (SCAL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Stem Cell Authority, Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Stem Cell Authority, Ltd. (SCAL) Average Enterprise Value

How has SCAL Enterprise Value performed in the past?

The current Enterprise Value of Stem Cell Authority, Ltd. (SCAL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Stem Cell Authority, Ltd. (SCAL) Enterprise Value vs. Peers

How is SCAL’s Enterprise Value compared to its peers?

Stem Cell Authority, Ltd.’s Enterprise Value is less than Healthcare Solutions Management Group, Inc. (13.81M), greater than Ceres Ventures, Inc. (6.61K), less than American Scientific Resources, Incorporated (0), less than Medite Cancer Diagnostics, Inc. (4.91M), greater than RenovaCare, Inc. (-2809960.00), greater than ViewRay, Inc. (-44998227.00), greater than Scopus BioPharma Inc. (-104458.00), less than Lowell Farms Inc. (18.13M), less than Cannabis Strategic Ventures (13.85M), less than Petlife Pharmaceuticals, Inc. (682.60K),

Build a custom stock screener for Stem Cell Authority, Ltd. (SCAL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Stem Cell Authority, Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Stem Cell Authority, Ltd. (SCAL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Stem Cell Authority, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.